Cholangiocyte (large 2)

[{"image":"https://icons.cdn.biorender.com/w75xh75/5be1f29e6f3d0b12005a99e4/5be1f2746f3d0b12005a99d7.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5be1f29e6f3d0b12005a99e4/5be1f2746f3d0b12005a99d7.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5be1f29e6f3d0b12005a99e2/5be1f2746f3d0b12005a99d7.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5be1f29e6f3d0b12005a99e2/5be1f2746f3d0b12005a99d7.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66da0e033ccf015b9bb382ad/5be1f2746f3d0b12005a99d7.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66da0e033ccf015b9bb382ad/5be1f2746f3d0b12005a99d7.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66da0e033ccf015b9bb382ae/5be1f2746f3d0b12005a99d7.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66da0e033ccf015b9bb382ae/5be1f2746f3d0b12005a99d7.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66da0e033ccf015b9bb382af/5be1f2746f3d0b12005a99d7.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66da0e033ccf015b9bb382af/5be1f2746f3d0b12005a99d7.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66da0e033ccf015b9bb382b0/5be1f2746f3d0b12005a99d7.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66da0e033ccf015b9bb382b0/5be1f2746f3d0b12005a99d7.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66da0e033ccf015b9bb382b1/5be1f2746f3d0b12005a99d7.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66da0e033ccf015b9bb382b1/5be1f2746f3d0b12005a99d7.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66da0e033ccf015b9bb382b2/5be1f2746f3d0b12005a99d7.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66da0e033ccf015b9bb382b2/5be1f2746f3d0b12005a99d7.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66da0e033ccf015b9bb382b3/5be1f2746f3d0b12005a99d7.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66da0e033ccf015b9bb382b3/5be1f2746f3d0b12005a99d7.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66da0e033ccf015b9bb382b4/5be1f2746f3d0b12005a99d7.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66da0e033ccf015b9bb382b4/5be1f2746f3d0b12005a99d7.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66da0e033ccf015b9bb382b5/5be1f2746f3d0b12005a99d7.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66da0e033ccf015b9bb382b5/5be1f2746f3d0b12005a99d7.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66da0e033ccf015b9bb382b6/5be1f2746f3d0b12005a99d7.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66da0e033ccf015b9bb382b6/5be1f2746f3d0b12005a99d7.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66da0e033ccf015b9bb382b7/5be1f2746f3d0b12005a99d7.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66da0e033ccf015b9bb382b7/5be1f2746f3d0b12005a99d7.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66da0e033ccf015b9bb382b8/5be1f2746f3d0b12005a99d7.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66da0e033ccf015b9bb382b8/5be1f2746f3d0b12005a99d7.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66da0e033ccf015b9bb382b9/5be1f2746f3d0b12005a99d7.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66da0e033ccf015b9bb382b9/5be1f2746f3d0b12005a99d7.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66da0e033ccf015b9bb382ba/5be1f2746f3d0b12005a99d7.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66da0e033ccf015b9bb382ba/5be1f2746f3d0b12005a99d7.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66da0e033ccf015b9bb382bb/5be1f2746f3d0b12005a99d7.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66da0e033ccf015b9bb382bb/5be1f2746f3d0b12005a99d7.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66da0e033ccf015b9bb382bc/5be1f2746f3d0b12005a99d7.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66da0e033ccf015b9bb382bc/5be1f2746f3d0b12005a99d7.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66da0e033ccf015b9bb382bd/5be1f2746f3d0b12005a99d7.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66da0e033ccf015b9bb382bd/5be1f2746f3d0b12005a99d7.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66da0e033ccf015b9bb382be/5be1f2746f3d0b12005a99d7.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66da0e033ccf015b9bb382be/5be1f2746f3d0b12005a99d7.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66da0e033ccf015b9bb382bf/5be1f2746f3d0b12005a99d7.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66da0e033ccf015b9bb382bf/5be1f2746f3d0b12005a99d7.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66da0e033ccf015b9bb382c0/5be1f2746f3d0b12005a99d7.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66da0e033ccf015b9bb382c0/5be1f2746f3d0b12005a99d7.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66da0e033ccf015b9bb382c1/5be1f2746f3d0b12005a99d7.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66da0e033ccf015b9bb382c1/5be1f2746f3d0b12005a99d7.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66da0e033ccf015b9bb382c2/5be1f2746f3d0b12005a99d7.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66da0e033ccf015b9bb382c2/5be1f2746f3d0b12005a99d7.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66da0e033ccf015b9bb382c3/5be1f2746f3d0b12005a99d7.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66da0e033ccf015b9bb382c3/5be1f2746f3d0b12005a99d7.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66da0e033ccf015b9bb382c4/5be1f2746f3d0b12005a99d7.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66da0e033ccf015b9bb382c4/5be1f2746f3d0b12005a99d7.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66da0e033ccf015b9bb382c5/5be1f2746f3d0b12005a99d7.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66da0e033ccf015b9bb382c5/5be1f2746f3d0b12005a99d7.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66da0e033ccf015b9bb382c6/5be1f2746f3d0b12005a99d7.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66da0e033ccf015b9bb382c6/5be1f2746f3d0b12005a99d7.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66da0e033ccf015b9bb382c7/5be1f2746f3d0b12005a99d7.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66da0e033ccf015b9bb382c7/5be1f2746f3d0b12005a99d7.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66da0e033ccf015b9bb382c8/5be1f2746f3d0b12005a99d7.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66da0e033ccf015b9bb382c8/5be1f2746f3d0b12005a99d7.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66da0e033ccf015b9bb382c9/5be1f2746f3d0b12005a99d7.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66da0e033ccf015b9bb382c9/5be1f2746f3d0b12005a99d7.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66da0e033ccf015b9bb382ca/5be1f2746f3d0b12005a99d7.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66da0e033ccf015b9bb382ca/5be1f2746f3d0b12005a99d7.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66da0e033ccf015b9bb382cb/5be1f2746f3d0b12005a99d7.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66da0e033ccf015b9bb382cb/5be1f2746f3d0b12005a99d7.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66da0e033ccf015b9bb382cc/5be1f2746f3d0b12005a99d7.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66da0e033ccf015b9bb382cc/5be1f2746f3d0b12005a99d7.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66da0e033ccf015b9bb382cd/5be1f2746f3d0b12005a99d7.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66da0e033ccf015b9bb382cd/5be1f2746f3d0b12005a99d7.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66da0e033ccf015b9bb382ce/5be1f2746f3d0b12005a99d7.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66da0e033ccf015b9bb382ce/5be1f2746f3d0b12005a99d7.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66da0e033ccf015b9bb382cf/5be1f2746f3d0b12005a99d7.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66da0e033ccf015b9bb382cf/5be1f2746f3d0b12005a99d7.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66da0e033ccf015b9bb382d0/5be1f2746f3d0b12005a99d7.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66da0e033ccf015b9bb382d0/5be1f2746f3d0b12005a99d7.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66da0e033ccf015b9bb382d1/5be1f2746f3d0b12005a99d7.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66da0e033ccf015b9bb382d1/5be1f2746f3d0b12005a99d7.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66da0e033ccf015b9bb382d2/5be1f2746f3d0b12005a99d7.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66da0e033ccf015b9bb382d2/5be1f2746f3d0b12005a99d7.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66da0e033ccf015b9bb382d3/5be1f2746f3d0b12005a99d7.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66da0e033ccf015b9bb382d3/5be1f2746f3d0b12005a99d7.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66da0e033ccf015b9bb382d4/5be1f2746f3d0b12005a99d7.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66da0e033ccf015b9bb382d4/5be1f2746f3d0b12005a99d7.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66da0e033ccf015b9bb382d5/5be1f2746f3d0b12005a99d7.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66da0e033ccf015b9bb382d5/5be1f2746f3d0b12005a99d7.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66da0e033ccf015b9bb382d6/5be1f2746f3d0b12005a99d7.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66da0e033ccf015b9bb382d6/5be1f2746f3d0b12005a99d7.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66da0e033ccf015b9bb382d7/5be1f2746f3d0b12005a99d7.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66da0e033ccf015b9bb382d7/5be1f2746f3d0b12005a99d7.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66da0e033ccf015b9bb382d8/5be1f2746f3d0b12005a99d7.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66da0e033ccf015b9bb382d8/5be1f2746f3d0b12005a99d7.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66da0e033ccf015b9bb382d9/5be1f2746f3d0b12005a99d7.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66da0e033ccf015b9bb382d9/5be1f2746f3d0b12005a99d7.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66da0e033ccf015b9bb382da/5be1f2746f3d0b12005a99d7.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66da0e033ccf015b9bb382da/5be1f2746f3d0b12005a99d7.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66da0e033ccf015b9bb382db/5be1f2746f3d0b12005a99d7.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66da0e033ccf015b9bb382db/5be1f2746f3d0b12005a99d7.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66da0e033ccf015b9bb382dc/5be1f2746f3d0b12005a99d7.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66da0e033ccf015b9bb382dc/5be1f2746f3d0b12005a99d7.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66da0e033ccf015b9bb382dd/5be1f2746f3d0b12005a99d7.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66da0e033ccf015b9bb382dd/5be1f2746f3d0b12005a99d7.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66da0e033ccf015b9bb382de/5be1f2746f3d0b12005a99d7.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66da0e033ccf015b9bb382de/5be1f2746f3d0b12005a99d7.png"}]